Ardais Corporation

Biorepository to be launched at Duke for clinical research in cancer

Published in Oncology Business Week, May 30th, 2004

Ardais Corporation and Duke University Medical Center announced the establishment of a new biorepository that will provide human biomaterials and clinical data for clinical research in cancer to Duke's NCI-supported Breast SPORE programs as well as to the Duke Comprehensive Cancer Center.

The new biorepository, based on the pioneering biomaterials initiative begun 4 years ago by Duke and Ardais, will address the biomaterials requirements of Duke researchers as they conduct a new generation of clinical trials in which cancer is analyzed and treated at the molecular level. While cancer is the initial disease focus of the Biorepository, it will be expanded in the future to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Oncology Business Week

Source: Oncology Business Week (2004-05-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry